Atika Capital Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Atika Capital Management LLC

  • $874 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$43.34 - $65.91 $2.99 Million - $4.55 Million
-69,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$23.3 - $59.57 $1.61 Million - $4.11 Million
69,000 New
69,000 $3.78 Million
Q3 2019

Nov 14, 2019
SELL
$10.85 - $14.78 $1.11 Million - $1.52 Million
-102,600 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$15.0 - $19.81 $1.54 Million - $2.03 Million
102,600 New
102,600 $1.54 Million

Others Institutions Holding RCKT

# of Institutions
210
Shares Held
93.3M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $780M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email